Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen.
Oliva A, Mascellino MT, Cipolla A, D'Abramo A, De Rosa A, Savinelli S, Ciardi MR, Mastroianni CM, Vullo V. Oliva A, et al. Among authors: mastroianni cm. Int J Infect Dis. 2015 Apr;33:132-4. doi: 10.1016/j.ijid.2015.01.011. Epub 2015 Jan 15. Int J Infect Dis. 2015. PMID: 25597275 Free article.
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae.
Oliva A, Gizzi F, Mascellino MT, Cipolla A, D'Abramo A, D'Agostino C, Trinchieri V, Russo G, Tierno F, Iannetta M, Mastroianni CM, Vullo V. Oliva A, et al. Among authors: mastroianni cm. Clin Microbiol Infect. 2016 Feb;22(2):147-153. doi: 10.1016/j.cmi.2015.09.014. Epub 2015 Sep 25. Clin Microbiol Infect. 2016. PMID: 26409059 Free article.
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.
Oliva A, Cipolla A, Gizzi F, D'Abramo A, Favaro M, De Angelis M, Ferretti G, Russo G, Iannetta M, Mastroianni CM, Mascellino MT, Vullo V. Oliva A, et al. Among authors: mastroianni cm. Medicine (Baltimore). 2016 Feb;95(7):e2243. doi: 10.1097/MD.0000000000002243. Medicine (Baltimore). 2016. PMID: 26886594 Free PMC article.
Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp).
Oliva A, Scorzolini L, Castaldi D, Gizzi F, De Angelis M, Storto M, D'Abramo A, Aloj F, Mascellino MT, Mastroianni CM, Vullo V. Oliva A, et al. Among authors: mastroianni cm. J Infect. 2017 Jan;74(1):103-106. doi: 10.1016/j.jinf.2016.10.002. Epub 2016 Oct 25. J Infect. 2017. PMID: 27793662 No abstract available.
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
Oliva A, Scorzolini L, Cipolla A, Mascellino MT, Cancelli F, Castaldi D, D'Abramo A, D'Agostino C, Russo G, Ciardi MR, Mastroianni CM, Vullo V. Oliva A, et al. Among authors: mastroianni cm. J Antimicrob Chemother. 2017 Jul 1;72(7):1981-1984. doi: 10.1093/jac/dkx084. J Antimicrob Chemother. 2017. PMID: 28369424
JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus.
Zingaropoli MA, Iannetta M, Pontecorvo S, Anzivino E, Prezioso C, Rodio DM, Morreale M, D'Abramo A, Oliva A, Lichtner M, Cortese A, Frontoni M, Pietropaolo V, Francia A, Mastroianni CM, Vullo V, Ciardi MR. Zingaropoli MA, et al. Among authors: mastroianni cm. Biomed Res Int. 2018 Feb 27;2018:5297980. doi: 10.1155/2018/5297980. eCollection 2018. Biomed Res Int. 2018. PMID: 29682547 Free PMC article.
392 results